A swath of earnings reports from tech stocks triggered most of the after-hours action Thursday, and
was among those stocks plunging after the Internet giant
jarred Wall Street
with lower-than-expected earnings.
The search engine company, so accustomed lately to throttling past estimates, slid 7.4% postbell after coming in 3 cents below for the second quarter, according to Thomson Financial. Non-GAAP earnings came to $3.56 a share, impacted by higher-than-anticipated expenses. Shares of the Mountain View, Calif., company were down $40.58 to $507.77.
was another heavily traded loser even though the Redmond, Wash., software company
topped revenue expectations
in the fiscal fourth quarter and posted in-line income of 39 cents a share. Shares were losing 2.3% to $30.80.
missed fiscal first-quarter profit views by a penny a share and issued
soft next-quarter guidance
, as fellow Californian
swung to a second-quarter non-GAAP loss of 8 cents a share on $32.4 million in revenue. Analysts were looking for a break-even bottom line on $37 million in revenue.
Xilinx lost 4.9% to $27.30; Packeteer, which makes wide-area-network application-delivery systems, tumbled 8.9% to $7.60.
A number of tech stocks, however, were on the upswing. Among them was
, which climbed 7% after posting non-GAAP income that, at 30 cents a share, was nearly double what analysts had expected. Revenue likewise
came out on top
. Shares of the Milpitas, Calif., company flash-storage-card maker were changing hands at $59.85.
Advanced Micro Devices
swung to a loss
but raked in higher-than-expected sales of $1.38 billion, and
fiscal fourth-quarter profits
from a one-time tax break. The hard-disk-drive maker made $541 million, or 96 cents a share, compared with penny-a-share earnings last year.
AMD was up 5.8%, and Seagate traded 1.6% higher to $24.50.
Out of the tech sector, Sunnyvale, Calif.-based
leapt 11.9% to $168 after its second-quarter profit catapulted 79.5% year over year to 79 cents a share, which topped Street estimates by 13 cents.
was one of the biggest postclose winners on a percentage basis, vaulting 20.6% to $2.69, after the Food and Drug Administration approved its broad-spectrum antimicrobial-barrier topical cream containing a patented technology called NPI 32101.